FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jukka Rantanen

Research Profile

Occupations

Phenomena

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Jari Pajander; Kathrine Bjørneboe; Kenneth Brian Haugshøj; Pia Wahlberg; Jukka Rantanen
Foreign matter identification from solid dosage forms.
Pall Thor Ingvarsson; Niels Bent Larsen; Hanne Mørck Nielsen; Jukka Rantanen; Signe Tandrup Schmidt; Mingshi Yang; Peter Andersen; Dennis Christensen; Wouter Leonardus Joseph Hinrichs; Camilla Foged
Designing CAF-adjuvanted dry powder vaccines: Spray drying preserves the adjuvant activity of CAF01.
Sanni Matero; Sami Poutiainen; Jukka Rantanen; Frans van Den Berg; Jari Pajander
Towards better process understanding: Chemometrics and multivariate measurements in manufacturing of solid dosage forms.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jukka Rantanen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jari Pajander; Kathrine Bjørneboe; Kenneth Brian Haugshøj; Pia Wahlberg; Jukka Rantanen
Foreign matter identification from solid dosage forms.
Journal of pharmaceutical and biomedical analysis 2013;80():116-25.
2013: Pall Thor Ingvarsson; Niels Bent Larsen; Hanne Mørck Nielsen; Jukka Rantanen; Signe Tandrup Schmidt; Mingshi Yang; Peter Andersen; Dennis Christensen; Wouter Leonardus Joseph Hinrichs; Camilla Foged
Designing CAF-adjuvanted dry powder vaccines: Spray drying preserves the adjuvant activity of CAF01.
Journal of controlled release : official journal of the Controlled Release Society 2013;167(3):256-64.
2013: Sanni Matero; Sami Poutiainen; Jukka Rantanen; Frans van Den Berg; Jari Pajander
Towards better process understanding: Chemometrics and multivariate measurements in manufacturing of solid dosage forms.
Journal of pharmaceutical sciences 2013;102(5):1385-403.
2013: Johan P Boetker; Anette Müllertz; Jesper Ostergaard; Thomas Rades; Jukka Rantanen; Henrik Jensen
A new approach to dissolution testing by UV imaging and finite element simulations.
Pharmaceutical research 2013;30(5):1328-37.
2013: Holger Grohganz; Yan-Ying Lee; Jukka Rantanen; Mingshi Yang
The influence of lysozyme on mannitol polymorphism in freeze-dried and spray-dried formulations depends on the selection of the drying process.
International journal of pharmaceutics 2013;447(1-2):224-30.
2013: Feng Wan; Simon Bjerregaard; Adam Bohr; Camilla Foged; Morten Jonas Maltesen; Jukka Rantanen; Mingshi Yang
Critical solvent properties affecting the particle formation process and characteristics of celecoxib-loaded plga microparticles via spray-drying.
Pharmaceutical research 2013;30(4):1065-76.
2013: Jian X Wu; Frans van den Berg; Søren V Søgaard; Jukka Rantanen
Fast-track to a solid dispersion formulation using multi-way analysis of complex interactions.
Journal of pharmaceutical sciences 2013;102(3):904-14.
2013: Niels Peter Aae Christensen; Andrew D Bond; Kaho Kwok; Thomas Rades; Jukka Rantanen; Lynne S Taylor; Bernard Van Eerdenbrugh; Claus Cornett
Rapid insight into heating-induced phase transformations in the solid state of the calcium salt of atorvastatin using multivariate data analysis.
Pharmaceutical research 2013;30(3):826-35.
2013: K Kogermann; K Jeeger; A Penkina; K Predbannikova; Jukka Rantanen; Peep Veski; K Naelapää
Dissolution testing of amorphous solid dispersions.
International journal of pharmaceutics 2013;444(1-2):40-6.
2013: Dhara Raijada; Andrew D Bond; Claus Cornett; Flemming H Larsen; Haiyan Qu; Jukka Rantanen
Exploring the solid-form landscape of pharmaceutical hydrates: transformation pathways of the sodium naproxen anhydrate-hydrate system.
Pharmaceutical research 2013;30(1):280-9.
2012: Kaisa Naelapää; Jukka Rantanen; Jacco van de Streek; Andrew D Bond
Complementing high-throughput X-ray powder diffraction data with quantum-chemical calculations: Application to piroxicam form III.
Journal of pharmaceutical sciences 2012;101(11):4214-9.
2012: Niels Peter Aae Christensen; Claus Cornett; Jukka Rantanen; Lynne S Taylor
Disproportionation of the calcium salt of atorvastatin in the presence of acidic excipients.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2012;82(2):410-6.
2012: Johan Boetker; Adrian Hawley; Thomas Rades; Jukka Rantanen; Ben J Boyd
Structural elucidation of rapid solution-mediated phase transitions in pharmaceutical solids using in situ synchrotron SAXS/WAXS.
Molecular pharmaceutics 2012;9(9):2787-91.
2012: Jian X Wu; Dengning Xia; Mingshi Yang; José Manuel Amigo; Thomas Rades; Frans van den Berg; Jukka Rantanen
A novel image analysis methodology for online monitoring of nucleation and crystal growth during solid state phase transformations.
International journal of pharmaceutics 2012;433(1-2):60-70.
2012: Dengning Xia; Fude Cui; Haiyan Qu; Thomas Rades; Jukka Rantanen; Jian X Wu; Mingshi Yang
Solvent-mediated amorphous-to-crystalline transformation of nitrendipine in amorphous particle suspensions containing polymers.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2012;46(5):446-54.
2012: Urve Paaver; Jukka Rantanen; Peep Veski; Jyrki Heinämäki; Andres Lust; Sabiruddin Mirza; Karin Kogermann
Insight into the solubility and dissolution behavior of piroxicam anhydrate and monohydrate forms.
International journal of pharmaceutics 2012;431(1-2):111-9.
2012: Arnaud Baldinger; Lucas Clerdent; Jukka Rantanen; Mingshi Yang; Holger Grohganz
Quality by design approach in the optimization of the spray-drying process.
Pharmaceutical development and technology 2012;17(4):389-97.
2012: Kaisa Naelapää; Thomas Rades; Jukka Rantanen; Peep Veski; Johan Peter Boetker; Karin Kogermann
Polymorphic form of piroxicam influences the performance of amorphous material prepared by ball-milling.
International journal of pharmaceutics 2012;429(1-2):69-77.
2012: Jari Pajander; Jukka Rantanen; Stefania Baldursdottir; Jesper Ostergaard
Behaviour of HPMC compacts investigated using UV-imaging.
International journal of pharmaceutics 2012;427(2):345-53.
2012: Niels Peter Aae Christensen; Claus Cornett; Jukka Rantanen
Role of excipients on solid-state properties of piroxicam during processing.
Journal of pharmaceutical sciences 2012;101(3):1202-11.
2012: Stefania Baldursdottir; Anna Cecilia Jørgensen; Bruno Gallo Santacruz; Fang Tian; Jukka Rantanen
The influence of thermal history on the physical behavior of poly(ethylene glycol) (PEG).
Pharmaceutical development and technology 2012;17(2):195-203.
2011: Jian X Wu; Mingshi Yang; Frans van den Berg; Jari Pajander; Thomas Rades; Jukka Rantanen
Influence of solvent evaporation rate and formulation factors on solid dispersion physical stability.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2011;44(5):610-20.
2011: P Karmwar; J P Boetker; K A Graeser; Jukka Rantanen; Clare J Strachan; Thomas Rades
Investigations on the effect of different cooling rates on the stability of amorphous indomethacin.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2011;44(3):341-50.
2011: Johan P Bøtker; Claus Cornett; Pranav Karmwar; Jukka Rantanen; Clare J Strachan; Fang Tian; Zoran Zujovic; Thomas Rades
Assessment of crystalline disorder in cryo-milled samples of indomethacin using atomic pair-wise distribution functions.
International journal of pharmaceutics 2011;417(1-2):112-9.
2011: Yan-Ying Lee; Frans van den Berg; Jian X Wu; Mingshi Yang; Paul M Young; Jukka Rantanen
Particle size dependence of polymorphism in spray-dried mannitol.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2011;44(1-2):41-8.
2011: Johan P Boetker; Claus Cornett; Vishal Koradia; Anette Müllertz; Thomas Rades; Jukka Rantanen; Marja Savolainen; Fang Tian; Jesper Ostergaard
Insights into the early dissolution events of amlodipine using UV imaging and Raman spectroscopy.
Molecular pharmaceutics 2011;8(4):1372-80.
2011: Jesper Ostergaard; Claus Larsen; Susan Weng Larsen; Jukka Rantanen; Anan Yaghmur; Fengbin Ye; Henrik Jensen
Monitoring lidocaine single-crystal dissolution by ultraviolet imaging.
Journal of pharmaceutical sciences 2011;100(8):3405-10.
2011: Karin Kogermann; Jukka Rantanen; Peep Veski; Kaisa Naelapää
X-ray powder diffractometry in combination with principal component analysis--a tool for monitoring solid state changes.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2011;43(4):278-89.
2011: Vishal Koradia; Morten Allesø; Michiel Ringkjøbing-Elema; Anette Müllertz; Heidi Lopez de Diego; Ana Filipa Fontelonga de Lemos; Jukka Rantanen
Phase transformations of amlodipine besylate solid forms.
Journal of pharmaceutical sciences 2011;100(7):2896-910.
2011: Holger Grohganz; Delphine Gildemyn; Erik Skibsted; James M Flink; Jukka Rantanen
Rapid solid-state analysis of freeze-dried protein formulations using NIR and Raman spectroscopies.
Journal of pharmaceutical sciences 2011;100(7):2871-5.
2011: Pall Thor Ingvarsson; Mingshi Yang; Hanne Mørck Nielsen; Jukka Rantanen; Camilla Foged
Stabilization of liposomes during drying.
Expert opinion on drug delivery 2011;8(3):375-88.
2011: Haiyan Qu; Tommy Munk; Claus Cornett; Jian X Wu; Johan P Bøtker; Lars P Christensen; Jukka Rantanen; Fang Tian
Influence of temperature on solvent-mediated anhydrate-to-hydrate transformation kinetics.
Pharmaceutical research 2011;28(2):364-73.
2010: Fang Tian; Haiyan Qu; Anne Zimmermann; Tommy Munk; Anna C Jørgensen; Jukka Rantanen
Factors affecting crystallization of hydrates.
The Journal of pharmacy and pharmacology 2010;62(11):1534-46.
2010: Vishal Koradia; Heidi Lopez de Diego; Michiel Ringkjøbing Elema; Jukka Rantanen
Integrated approach to study the dehydration kinetics of nitrofurantoin monohydrate.
Journal of pharmaceutical sciences 2010;99(9):3966-76.
2010: Morten Allesø; Fang Tian; Claus Cornett; Jukka Rantanen
Towards effective solid form screening.
Journal of pharmaceutical sciences 2010;99(9):3711-8.
2010: Holger Grohganz; Delphine Gildemyn; Erik Skibsted; James M Flink; Jukka Rantanen
Towards a robust water content determination of freeze-dried samples by near-infrared spectroscopy.
Analytica chimica acta 2010;676(1-2):34-40.
2010: Holger Grohganz; Margot Fonteyne; Erik Skibsted; Thomas Falck; Bent Palmqvist; Jukka Rantanen
Classification of lyophilised mixtures using multivariate analysis of NIR spectra.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2010;74(2):406-12.
2010: F Tian; H Qu; M Louhi-Kultanen; Jukka Rantanen
Crystallization of a polymorphic hydrate system.
Journal of pharmaceutical sciences 2010;99(2):753-63.
2010: Kaisa Naelapää; Peep Veski; Henning Gjelstrup Kristensen; Jukka Rantanen; Poul Bertelsen
Building quality into a coating process.
Pharmaceutical development and technology 2010;15(1):35-45.
2009: Anna Cecilia Jørgensen; Clare J Strachan; Kati H Pöllänen; Vishal Koradia; Fang Tian; Jukka Rantanen
An insight into water of crystallization during processing using vibrational spectroscopy.
Journal of pharmaceutical sciences 2009;98(11):3903-32.
2009: Paula Lehto; Jaakko Aaltonen; Mikko Tenho; Jukka Rantanen; Jouni Hirvonen; Veli Pekka Tanninen; Leena Peltonen
Solvent-mediated solid phase transformations of carbamazepine: Effects of simulated intestinal fluid and fasted state simulated intestinal fluid.
Journal of pharmaceutical sciences 2009;98(3):985-96.
2009: Sabiruddin Mirza; Inna Miroshnyk; Jyrki Heinämäki; Osmo Antikainen; Jukka Rantanen; Pia Vuorela; Heikki Vuorela; Jouko Yliruusi
Crystal morphology engineering of pharmaceutical solids: tabletting performance enhancement.
AAPS PharmSciTech 2009;10(1):113-9.
2008: Paula Lehto; Jaakko Aaltonen; Pentti Niemelä; Jukka Rantanen; Jouni Hirvonen; Veli Pekka Tanninen; Leena Peltonen
Simultaneous measurement of liquid-phase and solid-phase transformation kinetics in rotating disc and channel flow cell dissolution devices.
International journal of pharmaceutics 2008;363(1-2):66-72.
2008: Karin Kogermann; Jaakko Aaltonen; Clare J Strachan; Kati Pöllänen; Jyrki Heinämäki; Jouko Yliruusi; Jukka Rantanen
Establishing quantitative in-line analysis of multiple solid-state transformations during dehydration.
Journal of pharmaceutical sciences 2008;97(11):4983-99.
2008: Meike Römer; Jyrki Heinämäki; Inna Miroshnyk; Niina Kivikero; Niklas Sandler; Jukka Rantanen; Jouko Yliruusi
Phase transformation of erythromycin A dihydrate during fluid bed drying.
Journal of pharmaceutical sciences 2008;97(9):4020-9.
2007: Karin Kogermann; J Axel Zeitler; Jukka Rantanen; Thomas Rades; Philip F Taday; Michael Pepper; Jyrki Heinämäki; Clare J Strachan
Investigating dehydration from compacts using terahertz pulsed, Raman, and near-infrared spectroscopy.
Applied spectroscopy 2007;61(12):1265-74.
2007: Sabiruddin Mirza; Inna Miroshnyk; Jukka Rantanen; Jaakko Aaltonen; Pasi Harjula; Eero Kiljunen; Jyrki Heinämäki; Jouko Yliruusi
Solid-state properties and relationship between anhydrate and monohydrate of baclofen.
Journal of pharmaceutical sciences 2007;96(9):2399-408.
2007: Meike Römer; Jyrki Heinämäki; Inna Miroshnyk; Niklas Sandler; Jukka Rantanen; Jouko Yliruusi
Phase transformations of erythromycin A dihydrate during pelletisation and drying.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2007;67(1):246-52.
2007: Karin Kogermann; Jaakko Aaltonen; Clare J Strachan; Kati Pöllänen; Peep Veski; Jyrki Heinämäki; Jouko Yliruusi; Jukka Rantanen
Qualitative in situ analysis of multiple solid-state forms using spectroscopy and partial least squares discriminant modeling.
Journal of pharmaceutical sciences 2007;96(7):1802-20.
2007: Jaakko Aaltonen; Clare J Strachan; Kati Pöllänen; Jouko Yliruusi; Jukka Rantanen
Hyphenated spectroscopy as a polymorph screening tool.
Journal of pharmaceutical and biomedical analysis 2007;44(2):477-83.
2007: J Axel Zeitler; Karin Kogermann; Jukka Rantanen; Thomas Rades; Philip F Taday; Michael Pepper; Jaakko Aaltonen; Clare J Strachan
Drug hydrate systems and dehydration processes studied by terahertz pulsed spectroscopy.
International journal of pharmaceutics 2007;334(1-2):78-84.
2007: Pekka Hoppu; Kirsi Jouppila; Jukka Rantanen; Staffan Schantz; Anne Juppo
Characterisation of blends of paracetamol and citric acid.
The Journal of pharmacy and pharmacology 2007;59(3):373-81.
2007: Fang Tian; Niklas Sandler; Jaakko Aaltonen; Carolin Lang; Dorothy J Saville; Keith C Gordon; Clare J Strachan; Jukka Rantanen; Thomas Rades
Influence of polymorphic form, morphology, and excipient interactions on the dissolution of carbamazepine compacts.
Journal of pharmaceutical sciences 2007;96(3):584-94.
2007: Clare J Strachan; Thomas Rades; Keith C Gordon; Jukka Rantanen
Raman spectroscopy for quantitative analysis of pharmaceutical solids.
The Journal of pharmacy and pharmacology 2007;59(2):179-92.
2007: Jukka Rantanen
Process analytical applications of Raman spectroscopy.
The Journal of pharmacy and pharmacology 2007;59(2):171-7.
2007: Marja Savolainen; Kirsi Jouppila; Outi Pajamo; Leena Christiansen; Clare J Strachan; Milja Karjalainen; Jukka Rantanen
Determination of amorphous content in the pharmaceutical process environment.
The Journal of pharmacy and pharmacology 2007;59(2):161-70.
2006: Jaakko Aaltonen; Paula Heinänen; Leena Peltonen; Hanna Kortejärvi; Veli Pekka Tanninen; Leena Christiansen; Jouni Hirvonen; Jouko Yliruusi; Jukka Rantanen
In situ measurement of solvent-mediated phase transformations during dissolution testing.
Journal of pharmaceutical sciences 2006;95(12):2730-7.
2006: Marjatta Louhi-Kultanen; Milja Karjalainen; Jukka Rantanen; Mikko Huhtanen; Juha Kallas
Crystallization of glycine with ultrasound.
International journal of pharmaceutics 2006;320(1-2):23-9.
2006: Sabiruddin Mirza; Jyrki Heinämäki; Inna Miroshnyk; Jukka Rantanen; Leena Christiansen; Milja Karjalainen; Jouko Yliruusi
Understanding processing-induced phase transformations in erythromycin-PEG 6000 solid dispersions.
Journal of pharmaceutical sciences 2006;95(8):1723-32.
2006: Anna Cecilia Jørgensen; Inna Miroshnyk; Milja Karjalainen; Kirsi Jouppila; Simo Siiriä; Osmo Antikainen; Jukka Rantanen
Multivariate data analysis as a fast tool in evaluation of solid state phenomena.
Journal of pharmaceutical sciences 2006;95(4):906-16.
2006: Paulus Seitavuopio; Jyrki Heinämäki; Jukka Rantanen; Jouko Yliruusi
Monitoring tablet surface roughness during the film coating process.
AAPS PharmSciTech 2006;7(2):E31.
2005: Sari Airaksinen; Milja Karjalainen; Anna Shevchenko; Sari Westermarck; Ella Leppänen; Jukka Rantanen; Jouko Yliruusi
Role of water in the physical stability of solid dosage formulations.
Journal of pharmaceutical sciences 2005;94(10):2147-65.
2005: Milja Karjalainen; Sari Airaksinen; Jukka Rantanen; Jaakko Aaltonen; Jouko Yliruusi
Characterization of polymorphic solid-state changes using variable temperature X-ray powder diffraction.
Journal of pharmaceutical and biomedical analysis 2005;39(1-2):27-32.
2005: Jukka Rantanen; Håkan Wikström; Francis E Rhea; Lynne S Taylor
Improved understanding of factors contributing to quantification of anhydrate/hydrate powder mixtures.
Applied spectroscopy 2005;59(7):942-51.
2005: Kati Pöllänen; Antti Häkkinen; Satu-Pia Reinikainen; Jukka Rantanen; Milja Karjalainen; Marjatta Louhi-Kultanen; Lars Nyström
IR spectroscopy together with multivariate data analysis as a process analytical tool for in-line monitoring of crystallization process and solid-state analysis of crystalline product.
Journal of pharmaceutical and biomedical analysis 2005;38(2):275-84.
2005: Paulus Seitavuopio; Jukka Rantanen; Jouko Yliruusi
Use of roughness maps in visualisation of surfaces.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2005;59(2):351-8.
2005: Antti Häkkinen; Kati Pöllänen; Milja Karjalainen; Jukka Rantanen; Marjatta Louhi-Kultanen; Lars Nyström
Batch cooling crystallization and pressure filtration of sulphathiazole: the influence of solvent composition.
Biotechnology and applied biochemistry 2005;41(Pt 1):17-28.
2005: Jukka Rantanen; Håkan Wikström; Rebecca Turner; Lynne S Taylor
Use of in-line near-infrared spectroscopy in combination with chemometrics for improved understanding of pharmaceutical processes.
Analytical chemistry 2005;77(2):556-63.
2005: Anna von Bonsdorff-Nikander; Satu Lievonen; Leena Christiansen; Milja Karjalainen; Jukka Rantanen; Jouko Yliruusi
Physical changes of beta-sitosterol crystals in oily suspensions during heating.
AAPS PharmSciTech 2005;6(3):E413-20.
2005: Sari Airaksinen; Milja Karjalainen; Niina Kivikero; Sari Westermarck; Anna Shevchenko; Jukka Rantanen; Jouko Yliruusi
Excipient selection can significantly affect solid-state phase transformation in formulation during wet granulation.
AAPS PharmSciTech 2005;6(2):E311-22.
2005: Niklas Sandler; Jukka Rantanen; Jyrki Heinämäki; Meike Römer; Martti Marvola; Jouko Yliruusi
Pellet manufacturing by extrusion-spheronization using process analytical technology.
AAPS PharmSciTech 2005;6(2):E174-83.
2004: Anna Cecilia Jørgensen; Jukka Rantanen; Pirjo Luukkonen; Sampsa Laine; Jouko Yliruusi
Visualization of a pharmaceutical unit operation: wet granulation.
Analytical chemistry 2004;76(18):5331-8.
2004: Anna Cecilia Jørgensen; Sari Airaksinen; Milja Karjalainen; Pirjo Luukkonen; Jukka Rantanen; Jouko Yliruusi
Role of excipients in hydrate formation kinetics of theophylline in wet masses studied by near-infrared spectroscopy.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2004;23(1):99-104.
2004: Anna Cecilia Jørgensen; Pirjo Luukkonen; Jukka Rantanen; Torben Schaefer; Anne Juppo; Jouko Yliruusi
Comparison of torque measurements and near-infrared spectroscopy in characterization of a wet granulation process.
Journal of pharmaceutical sciences 2004;93(9):2232-43.
2004: Mirna Fernández Cervera; Milja Karjalainen; Sari Airaksinen; Jukka Rantanen; Karin Krogars; Jyrki Heinämäki; Antonio Iraizoz Colarte; Jouko Yliruusi
Physical stability and moisture sorption of aqueous chitosan-amylose starch films plasticized with polyols.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2004;58(1):69-76.
2004: Sari Airaksinen; Milja Karjalainen; Eetu Räsänen; Jukka Rantanen; Jouko Yliruusi
Comparison of the effects of two drying methods on polymorphism of theophylline.
International journal of pharmaceutics 2004;276(1-2):129-41.
2004: Eetu Räsänen; Jukka Rantanen; Jukka-Pekka Mannermaa; Jouko Yliruusi
The characterization of fluidization behavior using a novel multichamber microscale fluid bed.
Journal of pharmaceutical sciences 2004;93(3):780-91.
2004: Niklas Laitinen; Osmo Antikainen; Jukka Rantanen; Jouko Yliruusi
New perspectives for visual characterization of pharmaceutical solids.
Journal of pharmaceutical sciences 2004;93(1):165-76.
2003: Eetu Räsänen; Jukka Rantanen; Jukka-Pekka Mannermaa; Jouko Yliruusi; Heikki Vuorela
Dehydration studies using a novel multichamber microscale fluid bed dryer with in-line near-infrared measurement.
Journal of pharmaceutical sciences 2003;92(10):2074-81.
2003: Karin Krogars; Jyrki Heinämäki; Milja Karjalainen; Jukka Rantanen; Pirjo Luukkonen; Jouko Yliruusi
Development and characterization of aqueous amylose-rich maize starch dispersion for film formation.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2003;56(2):215-21.
2003: Anna von Bonsdorff-Nikander; Milja Karjalainen; Jukka Rantanen; Leena Christiansen; Jouko Yliruusi
Physical stability of a microcrystalline beta-sitosterol suspension in oil.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2003;19(4):173-9.
2003: Paulus Seitavuopio; Jukka Rantanen; Jouko Yliruusi
Tablet surface characterisation by various imaging techniques.
International journal of pharmaceutics 2003;254(2):281-6.
2003: Sari Airaksinen; Pirjo Luukkonen; Anna Jørgensen; Milja Karjalainen; Jukka Rantanen; Jouko Yliruusi
Effects of excipients on hydrate formation in wet masses containing theophylline.
Journal of pharmaceutical sciences 2003;92(3):516-28.
2003: Anna von Bonsdorff-Nikander; Jukka Rantanen; Leena Christiansen; Jouko Yliruusi
Optimizing the crystal size and habit of beta-sitosterol in suspension.
AAPS PharmSciTech 2003;4(3):E44.
2002: Anna Jørgensen; Jukka Rantanen; Milja Karjalainen; Leonid Khriachtchev; Eetu Räsänen; Jouko Yliruusi
Hydrate formation during wet granulation studied by spectroscopic methods and multivariate analysis.
Pharmaceutical research 2002;19(9):1285-91.
2002: Leena Christiansen; Jukka Rantanen; Anna K von Bonsdorff; Milja Karjalainen; Jouko Yliruusi
A novel method of producing a microcrystalline beta-sitosterol suspension in oil.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2002;15(3):261-9.
2002: Mirja Ruotsalainen; Jyrki Heinämäki; Jukka Rantanen; Jouko Yliruusi
Development of an automation system for a tablet coater.
AAPS PharmSciTech 2002;3(2):E14.
2001: Pirjo Luukkonen; T Maloney; Jukka Rantanen; H Paulapuro; Jouko Yliruusi
Microcrystalline cellulose-water interaction--a novel approach using thermoporosimetry.
Pharmaceutical research 2001;18(11):1562-9.
2001: Marja Laasonen; Jukka Rantanen; Tuulikki Harmia-Pulkkinen; E Michiels; Raimo Hiltunen; Markku Räsänen; Heikki Vuorela
Near infrared reflectance spectroscopy for the fast identification of PVC-based films.
The Analyst 2001;126(7):1122-8.
2001: Eetu Räsänen; Jukka Rantanen; Anna Jørgensen; Milja Karjalainen; T Paakkari; Jouko Yliruusi
Novel identification of pseudopolymorphic changes of theophylline during wet granulation using near infrared spectroscopy.
Journal of pharmaceutical sciences 2001;90(3):389-96.
2001: Jukka Rantanen; Anna Jørgensen; Eetu Räsänen; Pirjo Luukkonen; Sari Airaksinen; Johanna Raiman; Kaisa Hänninen; Osmo Antikainen; Jouko Yliruusi
Process analysis of fluidized bed granulation.
AAPS PharmSciTech 2001;2(4):21.
2001: Pirjo Luukkonen; Jukka Rantanen; K Mäkelä; Eetu Räsänen; Jukka Tenhunen; Jouko Yliruusi
Characterization of wet massing behavior of silicified microcrystalline cellulose and alpha-lactose monohydrate using near-infrared spectroscopy.
Pharmaceutical development and technology 2001;6(1):1-9.
2001: Jukka Rantanen; S J Laine; Osmo Antikainen; Jukka-Pekka Mannermaa; O E Simula; Jouko Yliruusi
Visualization of fluid-bed granulation with self-organizing maps.
Journal of pharmaceutical and biomedical analysis 2001;24(3):343-52.
2000: Jukka Rantanen; Eetu Räsänen; Jukka Tenhunen; M Känsäkoski; Jukka-Pekka Mannermaa; Jouko Yliruusi
In-line moisture measurement during granulation with a four-wavelength near infrared sensor: an evaluation of particle size and binder effects.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2000;50(2):271-6.
2000: Jukka Rantanen; M Känsäkoski; J Suhonen; Jukka Tenhunen; Sanna Lehtonen; T Rajalahti; Jukka-Pekka Mannermaa; Jouko Yliruusi
Next generation fluidized bed granulator automation.
AAPS PharmSciTech 2000;1(2):E10.
2000: Jukka Rantanen; Osmo Antikainen; Jukka-Pekka Mannermaa; Jouko Yliruusi
Use of the near-infrared reflectance method for measurement of moisture content during granulation.
Pharmaceutical development and technology 2000;5(2):209-17.